Avoidable deaths until 48 [corrected] months of age among children from the 2004 Pelotas birth cohort

Luis Ramon Marques da Rocha Gorgot1, Iná Santos, Neiva Valle

  • 1Programa de Pós-Graduação em Epidemiologia, Universidade Federal de Pelotas, Rua General Osório 1227, Pelotas, RS, Brazil. lrmrgorgot@yahoo.com.br

Revista De Saude Publica
|February 24, 2011
PubMed

Insights

A high proportion of child deaths in the Pelotas Birth Cohort were avoidable. Improving death certificate quality is crucial for monitoring child health care effectiveness.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Child mortality remains a significant public health concern globally.
  • Identifying avoidable deaths is key to improving healthcare interventions and outcomes.
  • The Pelotas Birth Cohort provides a valuable dataset for studying child health trends in Southern Brazil.

Purpose of the Study:

  • To determine the proportion of avoidable child deaths within the 2004 Pelotas Birth Cohort.
  • To classify causes of avoidable mortality in children under five.
  • To compare avoidable mortality data between different healthcare systems.

Main Methods:

  • Analysis of 92 child deaths (2004-2008) from the Pelotas Birth Cohort.
  • Classification of causes using the Brazilian List of Avoidable Causes of Mortality.
  • Comparison of infant mortality data from a sub-study and the Mortality Information System (SIM).

Main Results:

  • The overall mortality coefficient was 22.2 per 1,000 live births.
  • Over three-quarters (70/92) of child deaths were classified as avoidable.
  • Avoidable infant deaths were attributed to inadequate maternal care during pregnancy and insufficient newborn care.

Conclusions:

  • A substantial proportion of child deaths in the cohort were preventable.
  • Enhancing the quality of death certificate data is essential for accurate monitoring.
  • Improved data quality can better utilize avoidable mortality as an indicator for maternal and child health services.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...